Early-stage cancer research funding supported by inaugural virtual auction by Cholangiocarcinoma Foundation

Article

CCF Bidding for the Cure, in partnership with Qtego, features 65 items up for bid to help raise $150,000 for the Foundation’s 15-year anniversary celebration.

SALT LAKE CITY, UT – Cholangiocarcinoma patients and scientists need help generating funding for research and treatment of early-stage cholangiocarcinoma, a rare but lethal bile duct cancer. To help in that effort, the Cholangiocarcinoma Foundation (CCF) is proud to announce its inaugural virtual auction, “CCF Bidding for the Cure,” with all proceeds dedicated to research.

The auction is in partnership with Qtego and runs from Sept. 24th to Oct. 2nd. Registration is open now for the premier event that also commemorates the Foundation’s 15-year anniversary. The organization’s 15th Anniversary Steering Committee has committed to raise $150,000 for cholangiocarcinoma research and the auction supports that cause while commemorating the nonprofit’s milestone.

“It is with great enthusiasm that we present CCF Bidding for the Cure with all proceeds to go to cholangiocarcinoma-specific research while also paying tribute to the Foundation’s achievement of 15 years in existence,” said Barbara Dupont, auction co-chair. “Cholangiocarcinoma is increasingly being diagnosed in America with more than 10,000 cases each year. We must act with urgency to earmark as many dollars as we can to support patients and research to render cholangiocarcinoma a treatable disease, and ultimately, discover a cure.”

The benefit fundraiser kicks off and culminates with a Facebook Live event on Friday, Sept. 24th, at 3:00 p.m. (ET), with entertainment, patient perspective, instructions and the live auction of featured items. The auction opens that same day and concludes at 9:00 p.m. (ET) on Saturday, Oct. 2nd.

Several one-of-a-kind items are available for participants who register for free for a chance to win with their highest bids while also supporting a worthy charity. A few of those unique items are:

  • New Hampshire Ski Weekend,
  • Personalized cholangiocarcinoma painted shoes,
  • Weekend St. Pete Beach stay,
  • FanX Salt Lake Comic Convention 2022 with two-night stay at City Creek Marriott,
  • Award-winning Hey Grill, Hey rubs, spices and swag
  • Tree of Life jewelry set
  • Original artwork with beautiful depictions of landscapes,
  • Glamping extravaganza in gorgeous Wildland Gardens,
  • South Carolina Beach trip, and more!

Of particular interest are the "Bundles of Hope" items up for bid. These gift baskets are curated with items representing a state, city or theme. Examples include; Beach Fun, Comfort and Care, Game Night, Bar-B-Cue, Just for Kids, Spa Day, and many other creature comforts perfect for families.

All items have been generously donated to raise essential funds for cancer research - one of the most impactful ways to support patients. In the last 15 years, the Foundation has given more than $2 million in research grants and is dedicated to funding more.

“We thank all the volunteers on the steering committee that have helped to contribute to this year's celebratory events and this auction. CCF is committed to shine it’s light on cholangiocarcinoma for all those affected by the lethal cancer and is dedicated to putting patients first with collaborative efforts to develop new, first-line treatments options,” said Kelley Giles, auction co-chair.

The Foundation is also accepting donations via text-to-give. Anyone can text CCFturns15 to 41444 to donate and help raise much-needed research funds. There’s also a special commemorative Christmas ornament that may be purchased at any time throughout the auction.

WHAT: CCF Bidding for the Cure - virtual auction

WHEN: Friday, Sept. 24, 3:00 p.m. (ET) to Saturday, Oct. 2, 9:00 (ET)

HOW: Register for free by visiting: https://cholangiocarcinoma.org/bidding-for-the-cure/

About cholangiocarcinoma: Cholangiocarcinoma, pronounced (koh-LAN-jee-oh-KAR-sih-NOH-muh), is a highly lethal and rare bile duct cancer of the liver with a poor prognosis. With approximately 10,000 cases a year being diagnosed in the United States, cholangiocarcinoma is the second most common primary liver cancer in the world. It is often diagnosed at advanced stages when treatment is only minimally effective, emphasizing the imminent need for novel therapies.

About the Cholangiocarcinoma Foundation (CCF): Founded in 2006, the Cholangiocarcinoma Foundation is a global 501(c) (3) non-profit organization. Its mission is to find a cure and improve the quality of life for those affected by bile duct cancer. CCF supports basic & translational research and raises awareness in the cholangiocarcinoma community through advocacy, education, collaboration, and research. For more information, please visit our website at cholangiocarcinoma.org.

Related Videos
Related Content